King Claire M, Barbara Cynthia, Prentice Andrew, Brenton James D, Charnock-Jones D Stephen
Department of Obstetrics and Gynaecology, University of Cambridge, The Rosie Hospital, Cambridge, UK.
Functional Genomics of Ovarian Cancer Laboratory, CR-UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, UK.
J Pathol. 2016 Jan;238(2):185-96. doi: 10.1002/path.4657.
Endometriosis is a common benign gynaecological condition affecting at least 10% of women of childbearing age and is characterized by pain--frequently debilitating. Although the exact prevalence is unknown, the economic burden is substantial (∼$50 billion a year in the USA alone) and it is associated with considerable morbidity. The development of endometriosis is inextricably linked to the process of menstruation and thus the models that best recapitulate the human disease are in menstruating non-human primates. However, the use of these animals is ethically challenging and very expensive. A variety of models in laboratory animals have been developed and the most recent are based on generating menstrual-like endometrial tissue that can be transferred to a recipient animal. These models are genetically manipulable and facilitate precise mechanistic studies. In addition, these models can be used to study malignant transformation in epithelial ovarian carcinoma. Epidemiological and molecular evidence indicates that endometriosis is the most plausible precursor of both clear cell and endometrioid ovarian cancer (OCCA and OEA, respectively). While this progression is rare, understanding the underlying mechanisms of transformation may offer new strategies for prevention and therapy. Our ability to pursue this is highly dependent on improved animal models but the current transgenic models, which genetically modify the ovarian surface epithelium and oviduct, are poor models of ectopic endometrial tissue. In this review we describe the various models of endometriosis and discuss how they may be applicable to developing our mechanistic understanding of OCCA and OEA.
子宫内膜异位症是一种常见的良性妇科疾病,影响着至少10%的育龄女性,其特征为疼痛——常常使人衰弱。尽管确切的患病率尚不清楚,但经济负担巨大(仅在美国每年就约500亿美元),且它与相当高的发病率相关。子宫内膜异位症的发生与月经过程有着千丝万缕的联系,因此最能重现人类疾病的模型是处于月经周期的非人灵长类动物。然而,使用这些动物在伦理上具有挑战性且成本非常高。已经开发出了多种实验动物模型,最新的模型基于生成可移植到受体动物体内的类似月经的子宫内膜组织。这些模型可进行基因操作,便于进行精确的机制研究。此外,这些模型可用于研究上皮性卵巢癌的恶性转化。流行病学和分子证据表明,子宫内膜异位症是透明细胞卵巢癌和子宫内膜样卵巢癌(分别为OCCA和OEA)最合理的前体。虽然这种进展很少见,但了解转化的潜在机制可能会为预防和治疗提供新策略。我们开展这项研究的能力高度依赖于改进的动物模型,但目前对卵巢表面上皮和输卵管进行基因改造的转基因模型对于异位子宫内膜组织来说并不是很好的模型。在这篇综述中,我们描述了子宫内膜异位症的各种模型,并讨论了它们如何适用于加深我们对OCCA和OEA的机制理解。